Phase III dose selection of marzeptacog alfa (activated) informed by population pharmacokinetic modeling: A novel hemostatic drug

por Faraj, Alan, Knudsen, Tom, Desai, Shraddha, Neuman, Linda, Blouse, Grant E., Simonsson, Ulrika S. H.
Publicado 2022

Model‐informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategy

por Faraj, Alan, van Wijk, Rob C., Neuman, Linda, Desai, Shraddha, Blouse, Grant E., Knudsen, Tom, Simonsson, Ulrika S. H.
Publicado 2023

Diurnal variation in salivary progesterone in fertile Indian women

por Patil, Suvarna, Patil, Netaji, Bhat, Rohit, Hardikar-Bhat, Pallavi, Jadhav, Dnyaneshwar, Dervankar, Omkar, Joglekar, Charudatta, Shinde, Rohini, Desai, Shraddha, Chavan, Dhanashree, Pise, Megha, Nandoskar, Ajit
Publicado 2022